Is it time for class I recommendation for sodium-glucose cotransporter-2 inhibitors in heart failure with mildly reduced or preserved ejection fraction?: An updated systematic review and meta-analysis
Background: In heart failure with reduced ejection fraction (HFrEF), sodium-glucose cotransporter-2 (SGLT2) inhibitors were demonstrated to lower cardiovascular mortality (CV death) and hospitalization for heart failure (HHF); however, the advantages of SGLT2 inhibitors in heart failure with mildly...
Saved in:
Main Author: | Treewaree S. |
---|---|
Other Authors: | Mahidol University |
Format: | Review |
Published: |
2023
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/82397 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Obesity and heart failure with preserved ejection fraction
by: Wattana Leowattana
Published: (2020) -
Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: The Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial
by: Lam, C.S.P., et al.
Published: (2016) -
Heart failure with preserved ejection fraction in women: The dutch queen of hearts program
by: den Ruijter H, et al.
Published: (2016) -
Seipin Knockout Mice Develop Heart Failure With Preserved Ejection Fraction
by: Bai, B., et al.
Published: (2021) -
Cornell product is an ECG marker of heart failure with preserved ejection fraction
by: Tan, Eugene SJ, et al.
Published: (2023)